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Abstract
Obesity is associated with metabolic perturbations including liver and adipose tissue inflammation, insulin resistance, and
type 2 diabetes. Omega-6 fatty acids (v6) promote and omega-3 fatty acids (v3) reduce inflammation as they can be
metabolized to pro- and anti-inflammatory eicosanoids, respectively. 12/15-lipoxygenase (12/15-LO) enzymatically produces
some of these metabolites and is induced by high fat (HF) diet. We investigated the effects of altering dietary v6/v3 ratio
and 12/15-LO deficiency on HF diet-induced tissue inflammation and insulin resistance. We examined how these conditions
affect circulating concentrations of oxidized metabolites of v6 arachidonic and linoleic acids and innate and adaptive
immune system activity in the liver. For 15 weeks, wild-type (WT) mice were fed either a soybean oil-enriched HF diet with
high dietary v6/v3 ratio (11:1, HFH), similar to Western-style diet, or a fat Kcal-matched, fish oil-enriched HF diet with a low
dietary v6/v3 ratio of 2.7:1 (HFL). Importantly, the total saturated, monounsaturated and polyunsaturated fat content was
matched in the two HF diets, which is unlike most published fish oil studies in mice. Despite modestly increased food intake,
WT mice fed HFL were protected from HFH-diet induced steatohepatitis, evidenced by decreased hepatic mRNA expression
of pro-inflammatory genes and genes involved in lymphocyte homing, and reduced deposition of hepatic triglyceride.
Furthermore, oxidized metabolites of v6 arachidonic acid were decreased in the plasma of WT HFL compared to WT HFH-
fed mice. 12/15-LO knockout (KO) mice were also protected from HFH-induced fatty liver and elevated mRNA markers of
inflammation and lymphocyte homing. 12/15-LOKO mice were protected from HFH-induced insulin resistance but reducing
dietary v6/v3 ratio in WT mice did not ameliorate insulin resistance or adipose tissue inflammation. In conclusion, lowering
dietary v6/v3 ratio in HF diet significantly reduces steatohepatitis.
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Introduction
Obesity has reached pandemic levels taking a significant toll on
the health of adults and children. Obesity is associated with a
range of metabolic maladies, including insulin resistance, dyslipi-
demia, nonalcoholic fatty liver disease (NAFLD) and hypertension,
collectively grouped into the so-called metabolic syndrome [1,2,3].
Individuals with metabolic syndrome frequently exhibit pro-
inflammatory metabolic profiles and have increased risk for
developing type 2 diabetes and cardiovascular disease. The
obesity-associated low-grade chronic inflammatory state in meta-
bolic tissues, including adipose, liver, and muscle, contributes to
insulin resistance and metabolic dysfunction that results from
nutrient excess [4]. A variety of interventions to inhibit inflam-
matory pathways have been shown to have beneficial effects on
metabolic function in rodent models of obesity and human obesity
[4].
A new area of promising research in therapeutic approaches
against obesity and related metabolic diseases is the use of anti-
inflammatory nutrients provided through diet. The average
Western-style diet is highly enriched in polyunsaturated omega-6
fatty acids (v6) and relatively deficient in omega-3 fatty acids (v3),
reaching the estimated dietary v6/v3 ratio of 10–20:1 [5].
Omega-6 and v3 fatty acids are functionally distinct and their
metabolites often have the opposing physiologic functions. While
diets rich in v6 are generally pro-inflammatory and promote
insulin resistance, the converse is true for v3-enriched diets [6].
Corresponding to Western diets, standard high fat (HF) diet chows
in rodent diet-induced obesity models are typically enriched for
saturated fatty acids and polyunsaturated v6 fatty acids. HF chow
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consumption increases tissue percentage of saturated fatty acids
and polyunsaturated v6 fatty acids, decreases tissue percentage of
v3, and directly activates pro-inflammatory toll-like receptor 4
(TLR4) signaling [7,8]. Thus, excessive amount of v6 and a very
high v6/v3 ratio in the diet are associated with and thought to be
casual in the pathogenesis of many diseases, including cardiovas-
cular disease, cancer and inflammatory and autoimmune diseases
[5]. The reduction of v6/v3 ratio has also shown to be beneficial
in the liver studies [9,10]. Conversely, diets enriched with v3 have
been shown to reduce hypertriglyceridemia [11], fatty liver disease
[12,13], and improve renal function in type 2 diabetics [14].
Omega-6 and v3 polyunsaturated fatty acids can be non-
enzymatically oxidized and are also substrates for oxidation by
lipoxygenases (LO), cyclooxygenases, and epoxygenases. In
particular, 12/15-LO catalyzes the insertion of molecular oxygen
into the v6 arachidonic acid and linoleic acid; 12- and 15-
hydroxy-eicosatetraenoic acids (HETE) are 12/15-LO products of
arachidonic acid and 9- and 13- hydroxy-octadecadienoic acids
(HODE) are 12/15-LO products of linoleic acid, all of which are
pro-inflammatory. We have previously demonstrated that 12/15-
LO knockout (KO) mice are protected from insulin resistance and
adipose tissue inflammation induced by a short-term feeding with
v6-enriched HF diet [15].
In this study we aimed at investigating the long-term effects of
altering dietary v6/v3 ratio in HF diet induced obesity in wild-
type (WT) mice with focus on the liver and adipose tissue
inflammation. We gave careful consideration on the design of the
diets so that the amount of total saturated, monounsaturated and
polyunsaturated fatty acids was the same in each HF diet.
Moreover, the total amount of dietary fat, the ratios of v6 to v3,
and the amount of total eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) in our low v6/v3 ratio diet are
more relevant to the ratios and doses used in human studies which
are significantly lower in comparison to the majority of published
rodent studies investigating the anti-inflammatory effects of v3-
supplementation [16,17,18,19,20]. We assessed the circulating
concentration of oxidized metabolites of pro-inflammatory v6
arachidonic and linoleic fatty acids and examined markers of both
innate and adaptive immune systems in liver tissue. Lastly, we
sought to delineate the effects of 12/15-LO deficiency on hepatic
steatosis in the chronic v6-enriched diet obese rodent model.
Experimental Procedures
Animal studies
All mouse procedures were performed in accordance with the
Guide for Care and Use of Laboratory Animals of the National
Institutes of Health and were approved by the University of
California, San Diego, Animal Subjects Committee (protocol
#S99173). All efforts were made to minimize pain and distress
during animal husbandry and experimental assessments. Four-
teen- to 15-week old male C57BL/6J WT mice (Jackson
Laboratory, Bar Harbor, ME) were fed with normal control
(NC, n = 7) rodent diet Purina 5001 (13% calories from fat;
LabDiet, St. Louis, MO), high fat diet with high dietary v6/v3
ratio of 11:1 (HFH, n = 7; 46% calories from fat), representing
typical Western diet, or high fat diet with low dietary v6/v3 ratio
of 2.7:1 (HFL, n = 8; 46% calories from fat), Table 1. Both HF
diets were custom designed and manufactured by TestDiet (PMI
Nutrition International, St. Louis, MO) using their basic van Heek
standard obesogenic diet 58V8. The HFH fat components were
lard and soybean oil, the HFL fat components were lard, soybean
oil, and Menhaden fish oil. Care was taken to ensure palatability
and prevent reduced calorie intake in the HFL-fed mouse group,
challenges that have been previously reported in other fish oil/v3-
enriched diet studies [19,20]. Fish oil fragrance can lead to
reduced food intake, so both high fat diets were prepared with
bacon flavoring and anti-oxidant t-butylhydroquinone (0.002%
wt/wt) in order minimize potential odor-effects on food intake
with the HFL diet. Both HFL and HFH diets were developed in
pelleted form. Fifteen-week old male 12/15-LOKO mice (from
our in-house colony [15] were fed with HFH diet (n = 4). Mice
were housed under controlled light (12:12 light: dark) and climate
conditions with unlimited access to food and water. Mouse weights
and food intake were monitored daily for one week and then twice
a week for the next 9 weeks on respective diets. All mice were
sacrificed after 15–17 weeks into the respective diets to assess liver
pathophysiology and inflammatory gene expression, plasma
components, gonadal white adipose tissue (gWAT) weight and
macrophage infiltration. Mouse sacrifice was performed in a
matched way so that the average length of the feeding period was
the same in each group. Figure 1 shows the daily intake of total v3
FA and EPA+DHA for the mice in our study and a schematic of
the study groups. For comparison with the mouse daily dose in our
study, Figure 1 also shows an approximate EPA+DHA daily dose
commonly prescribed to an 80 kg human.
Assessment of Insulin Resistance by HOMA-IR
Homeostatic model assessment of insulin resistance (HOMA-
IR) was calculated as fasting plasma insulin (mU/mL) 6 fasting
blood glucose (mg/dL) 4405] [21]. Plasma insulin levels were
measured using the Insulin Ultrasensitive (Mouse) EIA method
(Alpco, Salem, NH). A single plasma sample with insulin level
outside of the linear range of the assay was been excluded from
analysis. Fasting whole blood glucose was measured using a hand-
held glucometer (OneTouch Ultra2, LifeScan, Inc. Milpitas, CA).
Histology and the Assessment of Hepatic Steatosis in
Mouse Livers
Livers were weighed, cut into small pieces and fixed in 10%
formalin for 24 h or freshly frozen in Optimal Cutting Temper-
ature compound (OCT). The formalin fixed tissues were
embedded in paraffin and sections of 4 mm thickness were
prepared. Haematoxylin and eosin stained sections were used for
histopathological evaluation of hepatic injury and Oil Red O-
stained frozen liver specimens was performed by the UCSD
Histology Core. Samples were analyzed by light microscopy and
the level of triglycerides assessed by ImageJ software (National
Institutes of Health, Bethesda, MD). All photos were taken by
NanoZoomer 2.0HT Slide Scanning System (Hamamatsu, Japan).
Flow cytometry
Adipose tissue stromal vascular cells (SVCs) were isolated and
analyzed by FACS as previously reported [22] with minor
modifications. Briefly, freshly harvested epididymal fat pads were
separately rinsed and minced in DPBS +1% BSA then treated with
1 mg/mL type II collagenase (Sigma) for 25 min in a 37uC
shaking water bath. Adipose tissue cell suspensions were filtered
through 100 mm mesh. SVCs were separated from floating
adipocytes by centrifugation, incubated in RBC lysis buffer
(eBioscience) for 5 min, then re-suspended in fresh DPBS +1%
BSA. SVCs were incubated with Fc Block (BD Biosciences) for
15 min and then stained for 30 min with fluorescent-conjugated
antibodies against F4/80 (Ab Serotec), CD11b (BD Biosciences),
and CD11c (BD Biosciences). Cells were washed two times and re-
suspended in DPBS +1% BSA and propidium iodide (Sigma).
Presence of the fluorescent stains in the SVCs was analyzed using a
Fish Oil-Enriched Diet Reduces Hepatic Inflammation
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FACS Calibur flow cytometer (BD Biosciences). Control SVCs
preparations, including unstained cells, PI-only stained cells, and
fluorescence-minus-one (FMO) stained cells, were used to set
gatings and compensation. Total macrophages were defined as
F4/80+CD11b+ cells, while M1-type macrophages were defined as
F4/80+CD11b+CD11c+ cells.
Detection and quantification of oxidized fatty acid profile
All plasma samples for analyses contained anti-oxidant cocktail
[DTPA (2 mM final) and butylated hydroxytoluene (500 mM
final)]. Levels of multiple fatty acid oxidation products (free plus
esterified) in plasma were quantified using liquid chromatography
online electrospray ionization tandem mass spectroscopy. Prepa-
ration and analysis of plasma samples was performed as previously
reported [23]. The lipid peroxidation products analyzed included
structurally specific species of HETE (5-, 8-, 9-, 11-, 12-, and 15-
HETE), HODE (9- and 13-HODE), oxo-octadecadienoic acids (9-
and 13-oxoODE) and their precursors arachidonic acid and
linoleic acid.
Gene expression
Liver tissue was preserved in RNAlater (Invitrogen, Carlsbad,
CA) and homogenized using the FastPrep 24 bead homogeniza-
tion system (MP Biomedicals, Santa Ana, CA). Total RNA was
isolated using RNeasy kit (Qiagen, Valencia, CA) and reverse
transcribed by SuperScript III First-Strand Synthesis System RT-
PCR Kit (Invitrogen) using oligodT primers according to the
manufacturer instructions. The concentration and purity of RNA
was assessed by NanoDrop (Thermo Scientific, Waltham, MA).
The 260/280 ratio of each sample was at or slightly above 2.
Additional on column DNAse digestion step was performed, and
‘no template’ and ‘no reverse transcriptase’ controls were run to
ascertain purity of reagents and the lack of genomic DNA
contamination, respectively. Individual samples were measured in
triplicate. Data were normalized against two reference housekeep-
ing genes: beta-2 microglobulin (B2m) and hydroxymethylbilane
synthase (Hmbs) which were chosen based on stable gene
expression levels, based on our pilot study. Others have also
found a stable invariant expression of these genes in the livers of
other high fat diet-induced obesity mouse models and hepatic cells
[24,25,26]. The PCR primers used to amplify each gene are: B2m
F-59-CCCCACTGAGACTGATACATACG-39 R-59-CGATCC-
CAGTAGACGGTCTTG-39, Ccr7 F- 59-GTACGAGTCGGT-
GTGCTTCAA-39 R-59-GGTAGGTATCCGTCATGGTCT-39,
Ccl19 F- 59-GTGATGGAGGGGTCAGGA-39 R-59-GGGATG-
GGACAGCCTAAACT-59, Ccl21 F-59-GTGATGGAGGGGG-
TCAGGA-39 R-59-GGGATGGGACAGCCTAAACT-39, Cxcl1
(KC) F- 59-CTGGGATTCACCTCAAGAACATC-39 R-59-CA-
GGGTCAAGGCAAGCCTC-39, Cxcl2/3 (Mip2) F-59-CCAC-
CAACCACCAGGCTAC-39 R-59-GCTTCAGGGTCAAGGG-
CAAA-39, Hmbs F-59-TGTGGTGGCGATGCTGAAA-39 R-
59-TTGTCTCCCGTGGACATA-39, Ifng F-59-ATGAACGC-
TACACACTGCATC-39 R-59-CCATCCTTTTGCCAGTTCC-
TC-39, Il10 F-59-GCTCTTACTGACTGGCATGAG-39 R-59-
CGCAGCTCTAGGAGCATGTG-39, Il12a F-59-CTGTGCC-
TTGGTAGCATCTATG-39 R-59-CGCAGAGTCTCGCCAT-
TATGAT-39, Il12b F-59-CTCAGAAGCTAACCATCTCCTG-
G-39 R-59-CACAGGTGAGGTTCACTGTTTC-39, Il18 F-59-
GACTCTTGCGTCAACTTCAAGG-39 R-59-CAGGCTGTC-
TTTTGTCAACGA-39, Srebp1 F-59-GCAGCCACCATCTAG-
CCTG-39 R-59-CAGCAGTGAGTCTGCCTTGAT-39, Tnfa F-
59-CCCTCACACTCAGATCATCTTCT-39 R-59-GCTACGA-
CGTGGGCTACAG-39. Quantitative Real-time PCR was per-
formed on a CFX96 RT-PCR Detection System (BioRad,
Hercules, CA, USA) by using Brilliant II SYBR Green
QPCRMaster Mix (Agilent Technologies, La Jolla, CA, USA).
Fold-change values were calculated using the 22DDCt method.
Data analysis
Repeated-measures one-way ANOVA was applied to body
weight with a Bonferroni post hoc test to determine significant
group differences over time. Two-tailed Student’s t-test was used
to analyze statistical significance between groups, as indicated in
the figure legends. Data are reported as mean 6 standard error of
the mean (SE), with significance at P,0.05, unless otherwise
noted. GraphPad software (La Jolla, CA) was used to perform
analyses and to construct graphs.
Table 1. Composition of diets.
HFH HFL
Omega-6 15.9% 12.5%
LA 15.7% 12.2%
AA 0.2% 0.3%
Omega-3 1.4% 4.6%
ALA 1.4% 1.1%
EPA+DHA 0.0% 3.5%
v6/v3 ratio 11 2.7
SFA 40.8% 41.5%
MUFA 42.0% 41.4%
PUFA 17.3% 17.1%
Total fat 46.3% 46.3%
Protein 18.2% 18.2%
Carbohydrate 35.5% 35.5%
Fatty acid subgroup values are represented as a percent of total fat. Total fat, protein, carbohydrate values are represented as a percent of total kcal of diets. HFH, high
dietary v6/v3 ratio; HFL, low dietary v6/v3 ratio; LA, linoleic acid; AA, arachidonic acid; ALA, alpha-linoleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid;
SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
doi:10.1371/journal.pone.0107658.t001
Fish Oil-Enriched Diet Reduces Hepatic Inflammation
PLOS ONE | www.plosone.org 3 September 2014 | Volume 9 | Issue 9 | e107658
Results
Lowering dietary v6/v3 increases food intake, but does
not significantly alter total body, liver or adipose tissue
weights in high fat diet induced obesity
To assess the metabolic effects of altering dietary v6/v3 ratio in
the context of a high fat diet, we fed WT mice isocaloric diets (46%
kcal from fat) containing polyunsaturated fat contributed primarily
from soybean oil (high v6/v3 ratio, HFH) or fish oil (low v6/v3
ratio, HFL), or low fat, normal chow (NC; 13% kcal from fat)
(Fig. 1A and B). The high fat diets (HFH and HFL) were carefully
designed to contain equivalent fat, protein and carbohydrate
content as well as equivalent total saturated, monounsaturated,
and polyunsaturated fatty acid content (Table 1). Both high fat
diets induced significant body weight gain past week 5 as
compared to NC (Fig. 2A). There was no significant difference
in weight gain over the period of the first 10 weeks or in the final
body weights (week 15) between WT mice fed HFH and HFL diets
(Fig. 2A and Table 2). Although WT mice on HFL diet consumed
significantly more calories daily, averaging over the period of the
week 5 to 10 of the study (P,0.001) (Fig. 2B), increased food
intake in the HFL group did not differentially affect liver or
gonadal white adipose tissue (gWAT) weight as a percent of total
body weight (Table 2). Finally, there were no differences in fasting
plasma insulin and glucose levels, HOMA-IR, or proinflammatory
M1-type macrophage content in gWAT between WT mice fed
HFH and HFL diets (Table 2).
Figure 1. Schematic of diets and mouse groups. (A) Schematic illustrates the dietary v6/v3 fatty acid ratio, and the mg/kg/day intake of total
v3 fatty acid, EPA, DHA and EPA+DHA in the HFH and HFL diets consumed by the mice. For comparison, the approximate mg/kg/day dose of EPA+
DHA for an 80 kg human taking a standard prescription of Lovaza fish oil (four 1 g capsules, containing 840 mg EPA+DHA each, per day) is shown. (B)
15-week diet regimens for WT mice: normal chow diet (13% Kcal from fat), high fat diet (46% kcal from fat) with high dietary v6/v3 ratio (HFH), or
high fat diet (46% kcal from fat) with low dietary v6/v3 (HFL). (C) 15-week diet regimens for WT and 12/15-LOKO mice: high fat diet (46% kcal from
fat) with high dietary v6/v3 ratio (HFH). FA, fatty acids; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid.
doi:10.1371/journal.pone.0107658.g001
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Lowering dietary v6/v3 reduces lymphocyte homing
response in the liver and decreases hepatic inflammation
and steatosis
As it was previously reported that v3 supplemented diet reduces
hepatic steatosis and inflammation [18,19], we next aimed to
characterize these parameters in our animal models by measuring
gene expression in liver tissue from the mouse groups. First we
assessed the stimulation of Th1-mediated immune responses which
generally lead to a pro-inflammatory phenotype and increased
abundance of effectors IFN-c and TNF-a. We found that HFL
diet significantly reduced the mRNA levels of Il12a and b (p35 and
p40 subunits) (P,0.05) and Il18 (P,0.05) as compared to HFH,
thus marking attenuation of the inflammatory Th1 phenotype
(Fig. 3A). Next, we assessed hepatic mRNA expression of
representative pro-inflammatory (Infg and Tnfa) and anti-inflam-
matory pathway (Il10) genes and neutrophil chemoattractant
genes, C-X-C motif ligand 1 (Cxcl1, KC) and microphage
inflammatory protein 2 (Mip2; Cxcl2/3). HFL diet had a
protective, anti-inflammatory effect where levels of Ifng (P,0.01)
and Tnfa (P,0.001) mRNA were near to normal chow (NC)
control levels, as compared to the effect of HFH diet (Fig. 3B).
Levels of Il10 and Cxcl1 mRNA were both significantly lower in
HFL vs. HFH diet-fed mice (P,0.05) (Fig. 3C). Next, the
lymphocyte homing response was examined. When chemokine
C-C motif ligands (CCL) 19 or 21 bind to lymphocyte-expressed
chemokine receptor (CCR) 7, this receptor is internalized and
lymphocytes stay trapped in an organ. Indeed, it has been shown
that the suppression of cytokine signaling protein-1 regulates
migration of CD4+ T cells into peripheral tissues via changes in
Ccr7 expression levels [27]. Accordingly, we observed a decrease
in the expression of Ccr7 (P,0.05) and increase in the expression
of Ccl19 (P,0.05) in HFH-fed animals, a phenotype that did not
exist in HFL diet-fed mice, suggesting that lower dietary v6/v3
ratio in the context of a high fat diet protects from lymphocyte
homing in the liver (Fig. 3D). Interestingly, HFL diet did not alter
high fat diet-induced infiltration of M1-type inflammatory
macrophages into gWAT, as determined by flow cytometry
analysis (Table 2). Histological analysis of H&E and Oil Red O
Figure 2. Body weight and food intake. The effect of varying dietary v6/v3 ratio in WT (NC n= 4), open circles; HFH n=7, black squares; and HFL
n= 8, gray triangles) mice on (A) body weight over fist 10 weeks of diet regimens and (B) food intake averaged over weeks 5 to 10 on the respective
diets. Values are mean 6SE. ***P,0.001 HFH vs. HFL. NC, normal control (chow); HFH, high dietary v6/v3 ratio; HFL, low dietary v6/v3 ratio.
doi:10.1371/journal.pone.0107658.g002
Table 2. Metabolic parameters in WT mice fed NC, HFH, and HFL diets.
NC HFH HFL
mean±SE mean±SE mean±SE t-testb
Parameter [unit] (n = 3–7)a (n =6–7) (n =7–8) p-value
Final body weight (BW) [g] 29.160.8 41.062.6 45.360.8 0.12
Liver weight [% BW] 5.760.3 5.060.3 5.260.4 0.67
gWAT weight [% BW] 2.360.3 4.460.3 4.160.1 0.50
Fasting plasma insulin [ng/mL] 0.3060.11 1.8260.56 2.6260.56 0.34
Fasting blood glucose [mg/dL] 11168 128620 158612 0.21
HOMA-IR 2.060.8 16.067.4 24.064.1 0.33
gWAT M1-type macrophages [% total macrophages] 18.961.7 80.667.0 89.361.0 0.21
NC, normal chow; HFH, high dietary v6/v3 ratio; HFL, low dietary v6/v3 ratio; HOMA-IR, homeostatic model assessment of insulin resistance; gWAT, gonadal white
adipose tissue.
aData were not available for liver weight, fasting insulin and glucose for 4 NC mice.
bStudent’s t-test was restricted to high fat diet groups (HFH vs. HFL). NC data are shown for comparison.
doi:10.1371/journal.pone.0107658.t002
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stained liver specimens demonstrated significantly less hepatic
steatosis in HFL as compared with HFH diet-fed mice (Fig. 3E).
Correspondingly, the expression level of the sterol regulatory
element-binding protein 1 gene (Srebp1) was significantly lower in
HFL vs. HFH diet fed mice (P,0.05) (Fig. 3F).
Oxidized metabolites of arachidonic acid are significantly
decreased in the plasma of HFL diet-fed mice
We have shown previously that 9- and 13-HODEs and 9- and
13-oxoODEs, products of free radical and enzymatic lipoxygen-
ase-mediated oxidation of the v6 linoleic acid were significantly
elevated in patients with non-alcoholic steatohepatitis (NASH)
[14]. Plasma concentrations of 12-, 15-, 11-, 8- and 9-HETE
oxidized metabolites of the v6 arachidonic acid were significantly
lowered in HFL vs. HFH diet fed mice (all P,0.05) (Fig. 4A).
There were no significant changes in the plasma concentrations of
oxidized metabolites of linoleic acid (HODEs and oxo-ODEs) or
v6 precursor concentrations of plasma arachidonic acid or linoleic
acid (Fig. 4B and C).
12/15-lipoxygenase deficiency prevents metabolic
defects and liver abnormalities associated with high fat,
high v6/v3 ratio diet
We and others have previously shown that 12/15-LOKO mice
are protected from HF diet-induced insulin resistance and adipose
tissue inflammation [15,28]. In this study, we were interested in
additionally studying the liver phenotypes of 12/15-LOKO mice
after HF feeding. 12/15-LOKO mice were subjected to HFH diet
for the same duration as WT mice and compared to WT HFH
mice to assess whether 12/15-lipoxygenase deficiency prevents
metabolic defects associated with high fat, high v6/v3 ratio diet
(Fig. 1C). There were no significant differences in the final total
body weights or gWAT mass expressed as a percentage of total
body weight among any of the groups (Fig. 5A) even though the
KO mice consumed significantly less calories daily, averaged over
weeks 5 to 10 of the study (P,0.01) (Fig. 5A). Gene expression
markers of lymphocyte homing response in liver were reduced
(Fig. 5B), as was expression of hepatic cytokine and chemoat-
tractant genes (Ifng, Tnfa, Il10 and Cxcl2/3) in KO HFH as
compared to WT HFH (all P,0.05) (Fig. 5C and D) similar to
that observed in the WT HFL group (Fig. 3B and C). In addition,
hepatic steatosis was also significantly less in the KO HFH as
compared to WT HFH mice (Fig. 5E and F). Although plasma
levels of oxidized metabolites of arachidonic acid were not
individually significantly reduced in the KO mice (Fig. 5G), they
were all trending lower as expected given that 12/15-lipoxygenase
is an enzymatic source of 12- and 15-HETE. Levels of oxidized
arachidonic acid metabolites of in the KO mice approximate those
observed in the HFL-fed WT mice (Fig. 4A).
Discussion
Nonalcoholic fatty liver disease has become the most common
liver disease in the United States and other developed countries. It
is commonly associated with the metabolic syndrome, obesity, type
2 diabetes and dyslipidemia. With the addition of inflammation,
NAFLD can progress to a more serious condition termed NASH
which then can progress to cirrhosis and hepatocellular carcinoma
[29]. Common causes of NAFLD, such as Western diet-induced
obesity and insulin resistance, are associated with macrophage
infiltration and inflammation in adipose, liver and muscle tissues of
humans and rodent models where a feed-forward cycle of
reciprocal adipocyte, hepatocyte, myocyte and macrophage
cross-talk results in the secretion of inflammatory factors and
further macrophage recruitment [4,30,31,32]. Thus, reducing this
chronic inflammation may be the key to combating obesity-
induced morbidities, insulin resistance and NAFLD. We aimed to
identify new strategic dietary approaches for mitigating HF diet-
induced inflammation and expand our knowledge of 12/15-LO
activity. This study is the first to show that reducing dietary v6/v3
fatty acid ratio, without any other diet composition changes, is
sufficient to protect WT mice from long-term HF diet-induced
steatohepatitis and to reduce plasma concentration of oxidized
metabolites of arachidonic acid. This reduction in dietary v6/v3
ratio did not protect the WT mice from HF diet-induced insulin
resistance or adipose tissue inflammation. In addition, we
demonstrate that 12/15-LO deficiency is sufficient to protect
from v6-enriched HF-diet induced steatohepatitis and, as we have
shown previously (41), total body insulin resistance.
Published rodent studies have shown that fish oil-based, v3-
enriched HF diets do not induce insulin resistance and adipose
tissue inflammation as do isocaloric v6-enriched HF diets (same %
calories from fat) [33,34,35]. Although reducing the dietary v6/
v3 ratio in our current study prevented development of liver
inflammation and steatosis, it did not prevent development of
insulin resistance (HOMA-IR). The beneficial effect of v3 fatty
acid supplementation on insulin sensitivity in other rodent HF
diet-induced models may have been potentiated by three factors,
1) high ratio of v6/v3 used in the ‘‘control’’ HF diets, 2)
megadoses of EPA+DHA in the fish oil HF diets, and 3) reduced
weight gain and food intake observed in mice consuming fish oil-
containing vs. standard HF diet. The v6/v3 ratios of HF control
diets used in several other studies are extreme, ranging from 34:1
to 86:1 [17,18]; in contrast, we used a ratio of 11:1, which is well
within the estimated dietary v6/v3 ratio range found in the
typical Western-style human diet (10-20:1) [5]. Based on our
calculations using their Methods sections, other rodent studies
have used extremely high EPA+DHA (long chain, anti-inflamma-
tory v3) doses of 1660-4370 mg/kg/day [16,36], at least 40–104X
the common therapeutic dose for an 80 kg human taking a
standard prescription of Lovaza fish oil (Figure 1). The EPA+
DHA dose in our study was 378 mg/kg/day, approximately 9X
the dose that an 80 kg human would consume taking a standard
prescription of Lovaza fish oil (Figure 1). In order to minimize
weight gain differences commonly attributable to reduced fish oil
diet intake, we prepared both our HFH and HFL diets in pelleted
form and with added bacon flavoring and anti-oxidants to mask
the fragrance of the fish oil in the HFL diet. Thus, in our study,
food intake and weight gain exhibited by mice in the HFL low v6/
v3 ratio group was not reduced. In fact, HFL group mice
consumed significantly more calories per day and tended to gain
more weight than HFH controls. Rodents in other fish oil diet
studies [17,18,19,20,37] where the fish oil-fed groups consumed
less calories and had reduced body weight gain compared to
controls may have experienced long-term insulin sensitizing effects
that were secondary to reduced weight gain, as has been previously
suggested [38]. Thus, the effects of v3 supplementation on insulin
resistance and glucose metabolism remain unclear.
Although it is known that inflammation mediated by the innate
immune response plays a critical role in obesity and NAFLD, the
role and importance of adaptive immune system is just beginning
to be unraveled. Among adaptive cells of the immune system, T
lymphocytes play a major role in the inflammatory response.
Thus, we hypothesized that an unregulated function of T cells
might be critical for NASH. Even though NASH is not considered
a Th1-polarized disease, several studies have shown that an
excessive production of Th1 proinflammatory cytokines and a
deficit of anti-inflammatory cytokines are components in its
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development [39]. CCR7, the receptor for the chemokine CCL19,
is expressed on naı¨ve T-cells, central memory T cells and Treg
cells among others. CCR7 regulates trafficking and homing of
lymphocytes to and within secondary lymphoid organs and
nonlymphoid tissues. Lack of CCR7 expression results in
accumulation of conventional T cells in diverse tissues and
immediate effector function. Furthermore, it has been demon-
strated that IFN-c is exclusively produced by CCR7- T cells [40].
Herein, we report that HF diet with a high dietary v6/v3 ratio
significantly reduced the mRNA expression of Ccr7 and increased
the expression of its ligand Ccl19, suggesting that T cells are
attracted to the liver and once within it, the microenvironment
Figure 3. Assessment of hepatic inflammation and steatosis. The effect of varying dietary v6/v3 ratio in high fat diet-fed WT mice on the
hepatic mRNA expression of (A) cytokines driving a Th1 profile, (B) pro/anti-inflammatory cytokines, (C) neutrophil chemoattractants, and (D)
regulators of lymphocyte homing response, all normalized to signal in WT NC mice (n = 7). (E) Haematoxylin-eosin and Oil red O staining of paraffin-
embedded liver sections. Quantitative grading scale assessing the quantity of hepatic triglycerides, normalized to signal in WT NC mice (expressed as
a fold increase in stained area relative to WT NC mice). (F) The effect of varying dietary v6/v3 ratio in high fat diet-fed WT mice on the hepatic mRNA
expression of sterol regulatory element-binding protein 1 (Srebp1) normalized to signal in WT NC mice. WT HFH: black bars; WT HFL: gray bars. Values
are mean6SE. 5-7 animals per group. *P,0.05, **P,0.01, ***P,0.001 HFH vs. HFL. Scale bar, 50 mm. WT NC SEs for genes Il12a (p35), Il12b (p40), Il18,
Ifng, Tnfa, Il10, Cxcl1 (KC), Cxcl2/3 (Mip2), Ccr7, Ccl19, Ccl21 and Srebp1 were 0.14, 0.09, 0.14, 0.08, 0.12, 0.17, 0.14, 0.13, 0.20, 0.21, 0.15, and 0.10,
respectively. WT NC SE value for oil red O stain was 0.15. NC, normal control (chow); HFH, high dietary v6/v3 ratio; HFL, low dietary v6/v3 ratio.
doi:10.1371/journal.pone.0107658.g003
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triggers their differentiation into CCR7- cells and retention in the
liver. Interestingly, this effect was significantly blunted in mice fed
a HF diet with decreased v6/v3 ratio or with 12/15-LO
deficiency. Lowering dietary v6/v3 ratio may be of clinical
relevance for reducing T-lymphocyte homing to the liver.
A role for IL-18 has been postulated in the development of
hepatic steatosis since both serum IL-18 concentration and hepatic
Il18 mRNA expression are elevated in lipopolysaccharide-treated
leptin deficient ob/ob mice and high fat diet fed-C57BL/6 mice
[41]. Proinflammatory cytokines IL-18 and IL-12 are closely
related and act synergistically since the administration recombi-
nant proteins IL-12 and IL-18 concurrently induces the produc-
tion of elevated levels of IFN-c and TNF-a in mice [41].
Interestingly, exogenous administration of IL-18 with IL-12 to
BALB/c mice induces fatty liver in an IFN-c dependent manner
[42], suggesting that both cytokines play an important role in the
inflammatory cascade leading to NAFLD. Different experimental
evidences point to an important role of IFN-c and TNF-a in
hepatic damage. The important role ascribed to IFN-c in hepatic
damage is based on its capability to prime Kupffer Cells upon the
co-recruitment of monocytes and lymphocytes into the inflamed
liver. Also, TNF-a contributes to insulin resistance and hepatic
steatosis in diet induced obesity [43]. Accordingly, in the present
study we have shown that both increased levels of Il12a, Il12b,
Il18, Ifng, Tnfa, and Il10 mRNA expression seen in the liver of
HFH fed mice and hepatic steatosis were reduced in HFL fed
mice.
Omega-6 and v3 polyunsaturated fatty acids are essential
dietary components in mammals and they compete for the same
enzymes for their processing, thus, the distribution of these
polyunsaturated fatty acids and their metabolite products in
plasma and tissue is directly influenced by dietary intake [5,6]. It
has been shown that the positive effects of v3 fatty acids are
connected to modulation of eicosanoid metabolic and signaling
pathways, which leads to alteration of polyunsaturated fatty acid
subtypes, inflammatory responses, and direct effects on gene
expression. Rodents and humans consuming diets rich in v3 fatty
acids, as a result, have reduced production of arachidonic acid and
eicosanoid oxidation products of arachidonic acid including
prostaglandin E2, leukotriene B4, and HETEs [44]. Interestingly,
when HETE is added to macrophages, it can cause inflammation
by up-regulating proinflammatory gene expression [45]. We have
previously demonstrated that 12/15-LO knockout in mice
counteracts the HF diet-induced increase in proinflammatory
macrophages and cytokine (IFN-c, IL-12p40 and TNF-a) and
chemokine (CXCL1) proteins in adipose tissue [15]. In this study,
we demonstrate that increased mRNA expression of hepatic Ifng
and Cxcl2/3 seen in HFH-fed WT mice were diminished in HFH-
fed 12/15-LOKO mice. The decreased hepatic Il10 mRNA
expression seen in HFL mice compared to HFH mice is not
surprising. It has been demonstrated that high levels of IL-18 and
IL-12 can induce IL-10 [46]. The production of IL-10 could be a
mechanism for attenuating the inflammatory response mediated
by IL-12. As a consequence, when IL-12 and IL-18 decreased, the
attempt to reduce the proinflammatory microenvironment is no
longer needed.
12/15-LO is an enzyme that catalyzes the insertion of
molecular oxygen into polyunsaturated fatty acids, including the
v6 arachidonic and linoleic acids and the v3 EPA and DHA. 12/
15-LO products of v6 substrates are involved in the signaling
processes of defense response and inflammation, activating Rac,
RhoA, MAP kinases, PKC, JNK and NF-kB [47,48]. We have
shown that 12/15-LO oxidation products activate TLR4 in
macrophages [49,50], suggesting a possible connection between
12/15-LO and TLR4 activation in the pathogenesis of insulin
resistance. 12/15-LO has also been implicated with obesity.
Figure 4. Plasma concentration of the major v6 fatty acids and their corresponding pro-inflammatory metabolites. The effect of
varying dietary v6/v3 ratio in high fat diet-fed WT mice on plasma concentrations of oxidized metabolites of (A) arachidonic acid and (B) linoleic acid.
(C) Plasma concentrations of arachidonic and linoleic acids. NC n= 3 (open bars), HFH n=7 (black bars), HFL n = 8 (gray bars). T-test analysis was
restricted to HF diet animals only. Values are mean 6SE. *P,0.05 HFH vs. HFL. NC, normal control (chow); HFH, high dietary v6/v3 ratio; HFL, low
dietary v6/v3 ratio; HETE, hydroxyeicosatetraenoic acid; HODE, hydroxyoctadecadienoic acid; oxoODE, oxooctadecadienoic acid.
doi:10.1371/journal.pone.0107658.g004
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Figure 5. Assessment of hepatic inflammation and steatosis in 12/15-LOKO mice on HFH diet. The effect of 12/15-lipoxygenase
deficiency on (A) terminal body weight, food intake and gonadal white adipose tissue (gWAT) weight expressed as percent total body weight, and
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Expression and activity of 12/15-LO is increased in liver and
adipocytes after HF diet consumption in rodents [45,51].
Previously we showed that 12/15-LO deficiency protected mice
from adipose tissue inflammation and, remarkably, prevented
systemic insulin resistance induced after 2–4 weeks (short-term)
HF diet feeding [15,28]. Longer-term (8–24 weeks) studies showed
similar results and also showed that HF induces 12/15-LO
activation and beta cell damage in pancreatic islets, which was
prevented in 12/15-LO deficient mice [28]. In the current study,
we show that 12/15-LO deficiency offers long-term (15 weeks)
protection from v6-enriched HF diet-induced fatty liver, liver
inflammation and lymphocyte homing to the liver. 12- and 15-
HETE are 12/15-LO oxidation products of v6 arachidonic acid
and 9- and 13-HODE are 12/15-LO products of v6 linoleic acid,
all of which are pro-inflammatory. Herein, we show that levels of
oxidized metabolites of arachidonic acid in plasma were signifi-
cantly reduced by lowering dietary v6/v3 ratio and tended to be
lower with 12/15-LO deficiency. Although reducing 12/15-LO
activity may seem like a potential therapeutic target for
counteracting high dietary v6/v3 ratio, a simpler strategy would
be to reduce dietary v6/v3 ratio which would decrease the levels
of v6-derived pro-inflammatory eicosanoids and increase the
levels of v3-derived anti-inflammatory eicosanoids produced
overall by cyclooxygenases, lipoxygenases, and epoxygenases.
In this study we examined novel dietary and therapeutic
approaches to reduce inflammation in obesity and metabolic
syndrome-related diseases. In particular, NASH is a serious liver
condition without any available treatments. These data strongly
suggest that either reducing dietary v6/v3 ratio or inhibiting the
enzymatic activity of 12/15-LO may protect against v6-rich
Western diet-induced steatohepatitis.
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